ELITE: E3 Ligase Inference for Tissue specific Elimination: A LLM Based E3 Ligase Prediction System for Precise Targeted Protein Degradation
Abstract
Targeted protein degradation (TPD) has transformed modern drug discovery by harnessing the ubiquitin-proteasome system to eliminate disease-driving proteins previously deemed undruggable. However, current approaches predominantly rely on a narrow set of ubiquitously expressed E3 ligases, such as Cereblon (CRBN) and Von Hippel-Lindau (VHL), which limits tissue specificity, increases systemic toxicity, and fosters resistance. Here, we present an AI-driven framework for the rational identification of tissue-specific E3 ligases suitable for precision-targeted degradation. Our model leverages an BERT-based protein language architecture trained on billions of sequences to generate contextual embeddings that capture structural and functional motifs relevant for E3-substrate compatibility. By integrating these embeddings with tissue-resolved protein-protein interaction data, the framework predicts ligase-target interactions that are both biologically plausible and context-restricted. This enables the prioritization of ligases capable of driving selective degradation of pathogenic proteins within disease-relevant tissues. The proposed approach offers a scalable path to expand the E3 ligase repertoire and advance TPD toward true precision medicine. The AI architecture used in this study builds upon a well-established, state-of-the-art protein language modeling framework rather than introducing a fundamentally new model design. The principal contribution instead lies in the deliberate engineering of a task-specific dataset that integrates large-scale protein sequence embeddings with tissue-resolved expression and interaction information tailored to targeted protein degradation. By curating and harmonizing these heterogeneous data modalities for the explicit purpose of identifying tissue-selective E3 ligases, we enable a generalizable foundation model to be effectively adapted to a previously unexplored application context. This data-centric advance underpins the framework's ability to generate biologically meaningful, context-aware predictions and represents a central contribution of the present work.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ELiAH2: update of the atlas of E3 ligases in human tissues by integrating tissue-specificity and docking properties of ligands for targeted protein degradation
서상재, Seunghun Song, … Hyojung Paik·bioRxiv·Oct 16, 2026
- An in-cell approach to evaluate E3 ligases for use in targeted protein degradation.
Yunan Zheng, Anamika Singh, … Ryan A. Mehl·Journal of the American Chemical SocietyPeer-reviewed·Jun 10, 2025
- E3-specific degrader discovery by dynamic tracing of substrate receptor abundance
Alexander Hanzl, Eleonora Barone, … Georg E. Winter·Journal of the American Chemical SocietyPeer-reviewed·Jan 5, 2023
- BioE3 enables the identification of bona fide targets of E3 ligases
O. Barroso-Gomila, L. Merino-Cacho, … J. D. Sutherland·bioRxiv·Aug 18, 2023
- Multi-scale classification decodes the complexity of the human E3 ligome
Arghya Dutta, Alberto Cristiani, … Ramachandra M. Bhaskara·Nature CommunicationsPeer-reviewed·Dec 25, 2025
- High-Resolution Mapping of the Human E3-Substrate Interactome using Ubicon Uncovers Network Architecture and Cancer Vulnerabilities
Tomoya Sakuma, Yuki Otani, Hideyuki Shimizu·bioRxiv·Apr 9, 2025